title: Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia.
authors.forename: A
authors.initials: A
authors.lastname: Porcellini
authors.forename: A
authors.initials: A
authors.lastname: Manna
authors.forename: L
authors.initials: L
authors.lastname: Moretti
authors.forename: M
authors.initials: M
authors.lastname: Carotenuto
authors.forename: M M
authors.initials: MM
authors.lastname: Greco
authors.forename: C
authors.initials: C
authors.lastname: Bodenizza
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000008:administration & dosage; D002648:Child; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000628:therapy*; D014182:Transplantation, Autologous
chemical_list: D003520:Cyclophosphamide; D002066:Busulfan